Trial intelligence / Profile preview

PREvention of atrial fibrillation in patients undergoing thoracic surgery for lung cancer

2007-003856-12Phase 3Completed

Sponsor
European Institute of Oncology
Start
Oct 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in Atrial fibrillation (AFib) and bronchial carcinoma comparing Metoprolol arm with Losartan arm (2 arms). Primary endpoint: Incidence of atrial fibrillation episodes after surgery. Started Oct 2007; status: completed.

02

Drugs

metoprolollosartan
03

Conditions

Atrial fibrillation (AFib)bronchial carcinoma

Beyond the preview

Go deeper on 2007-003856-12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-003856-12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call